{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:15:53Z","timestamp":1790270153449,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":3975,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1186\/s13613-015-0086-4","type":"journal-article","created":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T23:44:01Z","timestamp":1448322241000},"page":"44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Important drug classes associated with potential drug\u2013drug interactions in critically ill patients: highlights for cardiothoracic intensivists"],"prefix":"10.1016","volume":"5","author":[{"given":"Shadi","family":"Baniasadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrooz","family":"Farzanegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Alehashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1186\/s13613-015-0086-4_bb0010","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.2042-7174.2012.00221.x","article-title":"Drug\u2013drug interactions in the medical intensive care unit: an assessment of frequency, severity and the medications involved","volume":"20","author":"Smithburger","year":"2012","journal-title":"Int J Pharm Pract"},{"key":"10.1186\/s13613-015-0086-4_bb0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ccc.2006.02.005","article-title":"Principles and practices of medication safety in the ICU","volume":"22","author":"Kane-Gill","year":"2006","journal-title":"Crit Care Clin"},{"key":"10.1186\/s13613-015-0086-4_bb0020","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/cpt1977223322","article-title":"Drug interactions and multiple drug administration","volume":"22","author":"May","year":"1977","journal-title":"Clin Pharmacol Ther"},{"key":"10.1186\/s13613-015-0086-4_bb0025","unstructured":"Zarowitz BJ. Pharmacologic principles. In: Ayres SM, Grenvik A, Holbrook PR, hoemaker WC, editors. Textbook of critical care. 3rd ed. Philadelphia: W.B. Saunders; 1995. p. 1141\u201350."},{"key":"10.1186\/s13613-015-0086-4_bb0030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1472-8206.2008.00623.x","article-title":"Altered pharmacology in the intensive care unit patient","volume":"22","author":"Zagli","year":"2008","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1186\/s13613-015-0086-4_bb0035","first-page":"573","article-title":"Reasons provided by prescribers when overriding drug\u2013drug interaction alerts","volume":"13","author":"Grizzle","year":"2007","journal-title":"Am J Manag Care"},{"key":"10.1186\/s13613-015-0086-4_bb0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11096-006-9061-3","article-title":"Determinants of potential drug\u2013drug interaction associated dispensing in community pharmacies in the Netherlands","volume":"29","author":"Becker","year":"2007","journal-title":"Pharm World Sci"},{"key":"10.1186\/s13613-015-0086-4_bb0045","doi-asserted-by":"crossref","first-page":"548","DOI":"10.15537\/1658-3175.2909","article-title":"Extent of potential drug interactions among patients receiving anti-hypertensive medications","volume":"26","author":"Sweilehe","year":"2005","journal-title":"Saudi Med J"},{"key":"10.1186\/s13613-015-0086-4_bb0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11096-013-9764-1","article-title":"Potential drug\u2013drug interactions in internal medicine wards in hospital setting in Pakistan","volume":"35","author":"Ismail","year":"2013","journal-title":"Int J Clin Pharm"},{"key":"10.1186\/s13613-015-0086-4_bb0055","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/11532340-000000000-00000","article-title":"Drug\u2013drug interactions in cardiac and cardiothoracic intensive care units: an analysis of patients in an academic medical centre in the US","volume":"33","author":"Smithburger","year":"2010","journal-title":"Drug Saf"},{"key":"10.1186\/s13613-015-0086-4_bb0060","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/pds.3415","article-title":"Frequency and nature of drug\u2013drug interactions in the intensive care unit","volume":"22","author":"Askari","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1186\/s13613-015-0086-4_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/S1807-59322011000100003","article-title":"Prevalence of potential drug interactions in patients in an intensive care unit of a university hospital in Brazil","volume":"66","author":"Reis","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1186\/s13613-015-0086-4_bb0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1590\/S0103-507X2008000400006","article-title":"Potential drug interactions prevalence in intensive care units","volume":"20","author":"Hammes","year":"2008","journal-title":"Rev Bras Ter Intensiva"},{"key":"10.1186\/s13613-015-0086-4_bb0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/phar.1395","article-title":"Analysis of potential drug\u2013drug interactions in medical intensive care unit patients","volume":"34","author":"Uijtendaal","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1186\/s13613-015-0086-4_bb0080","unstructured":"Up-to-date[online]. Lexi-interact online. http:\/\/www.uptodate.com\/crlsql\/interact\/frameset.jsp. Accessed 15 Jan 2015."},{"key":"10.1186\/s13613-015-0086-4_bb0085","unstructured":"McEvoy GK, Snow ED (editors). AHFS: drug information. Bethesda: American Society of Health-System Pharmacists; 2012."},{"key":"10.1186\/s13613-015-0086-4_bb0090","unstructured":"World Health Organization. ICD-10 classifications of mental and behavioural disorder. Geneva: Clinical Descriptions and Diagnostic Guidelines; 2015."},{"key":"10.1186\/s13613-015-0086-4_bb0095","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4321\/S1886-36552007000400003","article-title":"Profile of drug interactions in hospitalized children","volume":"5","author":"Martinbiancho","year":"2007","journal-title":"Pharm Pract (Granada)"},{"key":"10.1186\/s13613-015-0086-4_bb0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1365-2710.2002.00434.x","article-title":"GPs\u2019 views on computerized drug interaction alerts: questionnaire survey","volume":"27","author":"Magnus","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"10.1186\/s13613-015-0086-4_bb0105","first-page":"25","article-title":"Antimicrobial drug interactions in the critically ill patients","volume":"8","author":"Pereira","year":"2013","journal-title":"Curr Clin Pharmacol."},{"key":"10.1186\/s13613-015-0086-4_bb0110","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1742-7843.2008.00217.x","article-title":"Developing an adverse drug reaction reporting system at a teaching hospital","volume":"102","author":"Baniasadi","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1186\/s13613-015-0086-4_bb0115","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3855\/jidc.4676","article-title":"Appropriate vancomycin use in a Malaysian tertiary hospital based on current HICPAC recommendations","volume":"8","author":"Islahudin","year":"2014","journal-title":"J Infect Dev Ctries"},{"key":"10.1186\/s13613-015-0086-4_bb0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.det.2008.07.011","article-title":"Oral antibiotic drug interactions of clinical significance to dermatologists","volume":"27","author":"Del Rosso","year":"2009","journal-title":"Dermatol Clin"},{"key":"10.1186\/s13613-015-0086-4_bb0125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/00002018-199716040-00004","article-title":"Clinically significant drug interactions with new immunosuppressive agents","volume":"16","author":"Mignat","year":"1997","journal-title":"Drug Saf"},{"key":"10.1186\/s13613-015-0086-4_bb0130","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1517\/14740331003739188","article-title":"QT prolongation in the intensive care unit: commonly used medications and the impact of drug\u2013drug interactions","volume":"9","author":"Smithburger","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"10.1186\/s13613-015-0086-4_bb0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/0976-3147.83574","article-title":"Utilization patterns of central nervous system drugs: a cross-sectional study among the critically ill patients","volume":"2","author":"John","year":"2011","journal-title":"J Neurosci Rural Pract"},{"key":"10.1186\/s13613-015-0086-4_bb0140","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1590\/S0104-11692009000200013","article-title":"Potential drug interactions in intensive care patients at a teaching hospital","volume":"17","author":"Lima","year":"2009","journal-title":"Rev Lat Am Enfermagem"},{"key":"10.1186\/s13613-015-0086-4_bb0145","unstructured":"Lexicomp online\u00ae, Carbamazepine: drug information. Hudson: Lexi-Comp, Inc.; 2015."},{"key":"10.1186\/s13613-015-0086-4_bb0150","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/00000542-200003000-00026","article-title":"Additive inhibition of nicotinic acetylcholine receptors by corticosteroids and the neuromuscular blocking drug vecuronium","volume":"92","author":"Kindler","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1186\/s13613-015-0086-4_bb0155","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00003246-200201000-00021","article-title":"Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient","volume":"30","author":"Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists, American College of Chest Physicians","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1186\/s13613-015-0086-4_bb0160","unstructured":"Lexicomp online\u00ae, Amiodarone: drug information. Hudson: Lexi-Comp, Inc.; 2015."},{"key":"10.1186\/s13613-015-0086-4_bb0165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/cc2980","article-title":"Science review: the use of proton pump inhibitors for gastric acid suppression in critical illness","volume":"9","author":"Brett","year":"2005","journal-title":"Crit Care"},{"key":"10.1186\/s13613-015-0086-4_bb0170","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/jac\/dkg089","article-title":"A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solution","volume":"51","author":"Johnson","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1186\/s13613-015-0086-4_bb0175","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/aas.12099","article-title":"Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review","volume":"57","author":"Krag","year":"2013","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1186\/s13613-015-0086-4_bb0180","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/aas.12508","article-title":"Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries","volume":"59","author":"Krag","year":"2015","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1186\/s13613-015-0086-4_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/dth.12003","article-title":"The clinical significance of drug interactions between dermatological and psychoactive medications","volume":"27","author":"Frew","year":"2014","journal-title":"Dermatol Ther"},{"key":"10.1186\/s13613-015-0086-4_bb0190","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/MNH.0b013e32832edcb2","article-title":"Drug interactions in transplant patients: what everyone should know","volume":"18","author":"Manitpisitkul","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1186\/s13613-015-0086-4_bb0195","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1124\/dmd.110.032268","article-title":"Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin","volume":"38","author":"Amundsen","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1186\/s13613-015-0086-4_bb0200","first-page":"725","article-title":"International comparisons in critical care: a necessity and challenge","volume":"13","author":"Wunsch","year":"2007","journal-title":"Curr Opin Crit Care"},{"key":"10.1186\/s13613-015-0086-4_bb0205","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/cc11140","article-title":"Clinical review: international comparisons in critical care\u2014lessons learned","volume":"16","author":"Murthy","year":"2012","journal-title":"Crit Care"},{"key":"10.1186\/s13613-015-0086-4_bb0210","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2147\/TCRM.S44205","article-title":"Clinically significant interactions between antiretroviral and co-prescribed drugs for HIV-infected children: profiling and comparison of two drug databases","volume":"9","author":"Oshikoya","year":"2013","journal-title":"Ther Clin Risk Manag"},{"key":"10.1186\/s13613-015-0086-4_bb0215","author":"Paw","year":"2010"},{"key":"10.1186\/s13613-015-0086-4_bb0220","unstructured":"Young P. Intensive care unit drug manual, 2nd ed. Wellington, New Zealand; 2013"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-015-0086-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13613-015-0086-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025007587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025007587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-015-0086-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:14:58Z","timestamp":1776669298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025007587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"alternative-id":["S2110582025007587"],"URL":"https:\/\/doi.org\/10.1186\/s13613-015-0086-4","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Important drug classes associated with potential drug\u2013drug interactions in critically ill patients: highlights for cardiothoracic intensivists","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-015-0086-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Baniasadi et al. 2015. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"44"}}